Kuehn Law, PLLC is investigating whether officers and directors of Arcus Biosciences breached their fiduciary duties through potential self-dealing. This legal inquiry could lead to damages and governance reforms benefiting shareholders. Long-term stockholders are encouraged to contact the law firm for a free consultation to protect their rights. The investigation highlights concerns about corporate governance and shareholder protection at Arcus Biosciences.
Arcus Biosciences, Inc. is the subject of a legal investigation into potential fiduciary breaches. For readers following the health sector, here is Pluang's market snapshot as of Oct 22, 2026 03:02 WIB: out of 150 priced US health stocks, 73 rose and 75 fell. Notable movers include Inovio Pharmaceuticals Inc (INO) down 20.79% at USD 0.80 with a typical hold time of 43 days and a Pluang order activity of 43% Sell / 57% Buy, Charles River Laboratories Intl. Inc (CRL) up 9.25% at USD 344.63 with 0% Sell / 100% Buy, and Liquidia Corporation Common Stock (LQDA) up 7.24% at USD 38.98 with 91% Sell / 9% Buy.
National Healthcare Properties (NHP) announced that Lindsay Gordon, its Executive Vice President and Head of Senior Housing, has been elected to the executive board of the American Senior Housing Association (ASHA). ASHA is a leading national organiz...
Akzo Nobel reported Q3 2026 earnings with revenue of $2.85 billion and EPS of $0.38, both below analyst estimates of $2.96 billion and $0.42 respectively. Despite these misses, the company's core profit exceeded expectations, indicating underlying st...
United Airlines reported a strong third-quarter revenue of $17.9 billion, up 17.4% year-over-year, and provided optimistic guidance for the fourth quarter. Jefferies raised its price target for United Airlines stock to $142 from $134, suggesting a 36...
OFG Bancorp reported third-quarter earnings per share of $1.33, surpassing analyst estimates of around $1.23. However, its revenue came in slightly below expectations at $185.7 million versus estimates near $187 million. The earnings beat was driven ...
SEI Investments is set to report its Q3 2026 earnings on October 21 after market close, with analysts projecting earnings per share of $1.59 and revenue of $658.54 million. These estimates indicate a strong year-over-year growth of 22.3% in earnings ...
